Publication: 43

Publication: 43

Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.

PubMed

DOI

Google Scholar

Citation:: Cancer vol 110 (3) 670-7

Year:: 2007
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Long-Term-Followup
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: CA-21115, CA-25224, CA-32102, CA-35101, CA-35195, CA-37404, CA-38926

Corr. Author:
Authors:: Amanda C Ashley Daniel J Sargent Steven R Alberts Axel Grothey Megan E Campbell Roscoe F Morton Charles S Fuchs Ramesh K Ramanathan Stephen K Williamson Brian P Findlay Henry C Pitot Richard M Goldberg

Networks:

Study: NCCTG-9741
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Colorectal Neoplasms, Disease Progression, Female, Fluorouracil, Humans, Leucovorin, Male, Middle Aged, Organoplatinum Compounds, Survival Rate, Treatment Outcome